DYNAVAX TECHNOLOGIES CORP

EMERYVILLE, CA How do I update this listing?

Dynavax Technologies Corp is based out of Emeryville. Discovers, develops and intends to commercialize innovative products to treat and prevent allergies, infectious diseases and chronic inflammatory diseases using proprietary approaches that alter immune system responses. Its clinical development programs are based on immunostimulatory sequences.Whalewisdom has at least 2 13G filings, and 151 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2010-05-25. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other

Create Alert

Contact Info

dynavax technologies corp
2100 POWELL STREET
EMERYVILLE CA    94608

Business Phone: 5108485100
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2010-05-25 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 181,000 181,000 0
2010-01-07 D BIOTECHNOLOGY Equity,Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 38,947,480 20,067,480 18,880,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ARNOLD ORONSKY, PH.D. subscription required
    DIRECTOR
DAVID M. LAWRENCE, M.D. subscription required
    DIRECTOR
DENISE M. GILBERT, PH.D. subscription required
    DIRECTOR
DENNIS CARSON, M.D. subscription required
    DIRECTOR
DINO DINA, M.D. subscription required
    EXECUTIVE OFFICER DIRECTOR
FRANCIS R. CANO, PH.D. subscription required
    DIRECTOR
JENNIFER LEW subscription required
    EXECUTIVE OFFICER
MARK KESSEL subscription required
    DIRECTOR
MICHAEL S. OSTRACH subscription required
    EXECUTIVE OFFICER
NANCY L. BUC subscription required
    DIRECTOR
PEGGY V. PHILIPS subscription required
    DIRECTOR
ROBERT L. COFFMAN, PH.D. subscription required
    EXECUTIVE OFFICER
STANLEY A. PLOTKIN, M.D. subscription required
    DIRECTOR
ZBIGNIEW JANOWICZ, PH.D. subscription required
    EXECUTIVE OFFICER

Elevate your investments